We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Misshapen Erythrocytes Detected by Light Scattering

By LabMedica International staff writers
Posted on 14 Nov 2011
A technique allows doctors to ascertain the healthy shape of red blood cells in just a few seconds by analyzing the light scattered off hundreds of cells at a time. More...


The method called Fourier Transform Light Scattering (FTLS) was developed on individual red blood cells (RBCs), where the pattern changed significantly with the diameter and dimple width of the cells.

Scientists at the University of Illinois (UIUC; Urbana-Champaign, IL, USA) pioneered the technique that will allow physicians to ascertain whether red blood cells have healthy shapes or are distorted. This is accomplished by measuring the scattered light from hundreds of cells simultaneously. The theory was that if light was shone on a sample of blood and analyzed, the light scattering off that sample, would yield a pattern, a sort of signature produced by the way light interacts with itself in a three-dimensional space. That pattern would be different from the pattern collected from blood containing mostly misshapen cells.

These light-cell interactions were too complicated to analyze with the usual mathematical tools The UIUC team applied the Born approximation to their findings and calculated what the appropriate scattering signature for healthy cells should be. The investigators then used this new healthy cell signature to identify the correct morphology of cells in a blood smear. The novel technique may allow for faster, accurate blood tests that could help doctors diagnose various types of anemia, and could be especially useful in resource-poor areas of the world.

A healthy erythrocyte looks like a disc with a depression, called a dimple, in the top and bottom. Stressed RBCs often have deeper dimples than healthy ones, giving the cells a deflated look; others may have shallow dimples or no dimples at all. Misshapen RBCs are a sign of serious illnesses, such as malaria and sickle cell anemia. Until recently, the only way to assess whether a person's erythrocytes were the correct shape was to look at them individually under a microscope, a time-consuming process for pathologists. The study was published in October 2011 in the journal Biomedical Optics Express.

Related Links:

University of Illinois




Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Turbidimetric Control
D-Dimer Turbidimetric Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.